SLGL

Sol-Gel Technologies (SLGL)

About Sol-Gel Technologies (SLGL)

Sol-Gel Technologies Ltd. operates as a clinical-stage dermatology company, which engages in the identification, development, and commercialization of topical dermatological drug products for the treatment of skin diseases. Its products include VERED, TWIN, and SIRS-T. The company was founded by David Avnir and Alon Seri-Levy on October 28, 1997 and is headquartered in Ness Ziona, Israel.

Details

Daily high

$74.70

Daily low

$71.26

Price at open

$71.34

52 Week High

$97.97

52 Week Low

$6.96

Market cap

241.3M

Dividend yield

0.00%

Volume

14,440

Avg. volume

40,913

P/E ratio

-210.08

Sol-Gel Technologies News